The N6-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma

Rongrong Zhao(Anhui Medical University), Gang Li(Inner Mongolia Medical University)
Frontiers in Immunology
July 20, 2021
Cited by 48


Related Papers